Live Breaking News & Updates on Octavio Espinoza

Stay updated with breaking news from Octavio espinoza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) CFO Octavio Espinoza Sells 5,873 Shares

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 5,873 shares of the company’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $86.01, for a total value of $505,136.73. Following the completion of the transaction, the chief financial officer now directly owns 23,882 […] ....

Octavio Espinoza , Stephens Investment Management Group , Ligand Pharmaceuticals Incorporated , News Ratings For Ligand Pharmaceuticals Daily , Quarter For Ligand Pharmaceuticals , Ashford Capital Management Inc , Norges Bank , Pacer Advisors Inc , Ligand Pharmaceuticals Stock , Villere St Denisj Co , Ligand Pharmaceuticals , Get Free Report , Pharmaceuticals Incorporated , Capital Management , Investment Management Group , Ligand Pharmaceuticals Daily ,

Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $90.00 at Roth Capital

Ligand Pharmaceuticals (NASDAQ:LGND – Get Rating) had its price objective upped by Roth Capital from $85.00 to $90.00 in a research note issued to investors on Friday, The Fly reports. Roth Capital currently has a buy rating on the biotechnology company’s stock. A number of other research analysts have also weighed in on LGND. StockNews.com […] ....

Hong Kong , Johnl Higgins , Octavio Espinoza , Ligand Pharmaceuticals , Ligand Pharmaceuticals Incorporated , Institutional Investors Weigh In On Ligand Pharmaceuticals , Venture Visionary Partners , News Ratings For Ligand Pharmaceuticals Daily , Ligand Pharmaceuticals Price Performance , Hong Kong Ltd , Get Rating , Roth Capital , Moderate Buy , Director John , Visionary Partners , Kong Ltd , Pharmaceuticals Incorporated , Ligand Pharmaceuticals Daily , Nasdaq Lgnd , Boost Price Target ,